13D Filing: Boyalife Investment Enters Into Agreement With Cesca Therapeutics Inc. (KOOL)

Page 2 of 67

Page 2 of 67 SEC Filing

CUSIP No. 157131103

(1)

NAME OF REPORTING PERSON:

Boyalife Investment Inc.

(2)

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [X]

(b) [_]

(3)

SEC USE ONLY

 

(4)

 

SOURCE OF FUNDS

Cash Reserve (See Item 3)

(5)

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(D) OR 2(E)

[_]

(6)

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

(7)

SOLE VOTING POWER

26,470,588 (1)

(8)

SHARED VOTING POWER

0

(9)

SOLE DISPOSITIVE POWER

26,470,588 (1)

(10)

SHARED DISPOSITIVE POWER

0

(11)

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

26,470,588 (1)

(12)

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES

[_]

 

(13)

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

20.3%

 

(14)

 

TYPE OF REPORTING PERSON

CO

 

(1)Consists of warrants to purchase 58,823,529 Shares
acquired by Boyalife Investment Inc. pursuant to the transaction described below. Boyalife Investment Inc. has also acquired a
debenture that is convertible upon the occurrence of certain specified events, into 122,058,824 Shares; however such 122,058,824
Shares have been excluded from the beneficial ownership of Boyalife Investment Inc. reported in this Schedule 13D because such
122,058,824 Shares are not acquirable within 60 days of February 13, 2016.

 

Explanatory Note

This Schedule 13D is being filed as a result
of a transaction with an initial closing occurring on February 13, 2016, and a subsequent closing occurring on February 16, 2016,
as further described herein.

2

Follow Thermogenesis Holdings Inc. (NASDAQ:THMO)

Page 2 of 67